1. HOME
2. Research Insight
3. Merck KGaA (Germany) and Waters Corporation (US) are Leading Players in the Chromatography Reagents Market

The Chromatography Reagents Market is projected to reach a valuation of USD 6.8 billion in 2024, with an anticipated surge to USD 11.5 billion by 2029, exhibiting a CAGR of 11.0% throughout the forecast period. Growth in the chromatography reagents market is mainly driven by factors such as Growing pharmaceutical and biopharmaceutical R & D activities, Rising concerns for food safety, and Growing utilization of chromatography in drug development and omics research. However, lack of skilled professionals and rising prices of organic solvents will affect market growth negatively during the forecast period.

Prominent players in the chromatography reagents market include Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Avantor, Inc. (US), Waters Corporation (US), Agilent Technologies, Inc.(US), Bio-Rad Laboratories, Inc. (US), Danaher Corporation (US), Chiron AS (Norway), Loba Chemie (India), GFS Chemicals, Inc. (US), Regis Technologies, Inc. (US), Tokyo Chemical Industry Co., Ltd (TCI) (Japan), Honeywell International Inc. (US), Shimadzu Corporation(Japan), Santa Cruz Biotechnology, Inc. (US), Restek Corporation (US), Spectrum Chemical Mfg. Corp. (US), Kanto Kagaku (Japan), Tedia Company, Inc. (US), ITW Reagents Division (Spain),Tosoh Corporation (Japan), Concord Technology Co., Ltd. (Tianjin), Thomas Baker (Chemicals) Pvt. Ltd.(India), Alpha Laboratories Ltd. (Hampshire), Spectrochem (India), Columbus Chemical Industry (WI).

To know about the assumptions considered for the study download the pdf brochure

These companies adopted strategies such as product launches, partnerships, collaborations, and acquisitions to strengthen their market presence in Chromatography reagents   market.

The largest player on the market for chromatography reagent was Thermo Fisher as of 2023. Thermo Fisher's strategy is to invest in acquisitions and new product launches with a view to strengthening its position on the market. It is focused on the acquisition of new customers in emerging markets such as China, India and South Korea with a focus on expansion. PPD, Inc., a leading global provider of clinical research services for the pharmaceutical and biotechnology industries, was acquired by the company on 8 December 2021. By adding clinical research services from PPD, the company has been able to improve its offering for customers of biotechnology and pharmaceutical companies in order to facilitate innovation and increase productivity during drug development processes. High impact innovation, expansion into high growth markets such as China and dealing with worldwide challenges to sustain growth are part of the company's growth strategy.

Merck holds second position in the market for Chromatography Reagents, during 2023. Merck Millipore also offers a range of chemicals for use in the pharmaceutical, biotechnological, food and cosmetic industries as well as research laboratories. The company has established itself as one of the leading players in the market with a strong product portfolio in the area of chromatography reagents. In order to satisfy the needs of its customers, Merck Millipore strongly pursues research and development. It has a strong presence in Asia, Latin America and Africa with an important focus on the developing markets of Asia. The Asia Pacific market is expected to grow at the highest compound annual growth rate over the next few years, which will provide a large customer base for its products. Merck intends to make targeted global investments and strengthen its position in the life sciences industry, with an aim of growing sales by 6 % per year on organic basis from 2025 onwards.

Waters Corporation, in particular in liquid chromatography and mass spectrometry, is a leader in analytical instruments. The company maintains financial stability, with 59% of its sales in the pharmaceutical sector, despite a slight drop in net profit. Profitability and strategic investments are also supported by effective cost management and commitment to research and development. Waters strategically invested in Megadalton Solutions for Charge Detection Mass Spectrometry (CDMS) technology, enhancing its capability in analyzing large proteins for cell and gene therapies. The company's commitment to the advancement of analysis technology and expertise is demonstrated by its cooperation with the University of Delaware and Biolnfra.

Related Reports:

Chromatography Reagents Market by Technology (LC( HPLC, UPLC, LPLC),GC, SFC, TLC), Type (Solvent(LC, GC), Derivatization Reagent (Acylation, Silylation), Ion-Pair Reagent, Buffer), Mechanism, User (Pharma, Academia, Hospital) - Global Forecast to 2029

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]